Table 1.
Variable, n (%) | Group 1: patients given atorvastatin 20 mg/day (n=110) | Group 2: patients given atorvastatin 40 mg/day (n=100) | P-value |
---|---|---|---|
Men | 110 (100) | 100 (100) | |
Age (years) | 60.4 (59.5, 61.1) | 61.3 (60.9, 64.5) | 0.877 |
Risk factors | |||
Arterial hypertension | 80 (72.7) | 86 (86) | 0.795 |
Current smoking | 70 (63.7) | 68 (68) | 0.925 |
Family history of ischemic heart disease | 45 (40.9) | 50 (50) | 0.826 |
Clinical angina to myocardial infarction | 50 (45.5) | 55 (55) | 0.918 |
Previous myocardial infarction | 20 (18.2) | 14 (14) | 0.858 |
History of cerebrovascular accident/transient ischemic attack | 5 (4.5) | 5 (5) | 1.0 |
Depth of lesion | |||
Q-wave myocardial infarction | 80 (72.7) | 77 (77) | 0.929 |
Non-Q-wave myocardial infarction | 30 (27.3) | 25 (25) | 0.885 |
Localization of myocardial infarction | |||
Posterior | 60 (54.5) | 50 (50) | 0.918 |
Posterior with capture of the right ventricle | 20 (18.2) | 15 (15) | 0.858 |
Front | 30 (27.3) | 32 (32) | 0.894 |
Acute heart failure | |||
Killip I | 90 (81.8) | 86 (86) | 0.932 |
Killip II | 10 (9.1) | 5 (5) | 0.786 |
Killip III | 5 (4.6) | 9 (9) | 0.786 |
Killip IV | 0 | 0 | 1.0 |
Note: P-value for significant difference between Groups 1 and 2 was <0.05.